InvestorsHub Logo
DonShimoda

DonShimoda

Posts by DonShimoda Board Date/Time
Over the past 12mo, TRIL has "outperformed" just Biotech Values 02/01/2016 08:52:51 PM
Alliqua (ALQA) Snapshot Alliqua, Inc. 10/05/2015 04:20:47 PM
Full Disclosure: I'm long ALQA. Hopefully, the following Biotech Values 10/05/2015 03:27:56 PM
It could have been Elk but I heard Ariad Pharmaceuticals, Inc. 08/30/2015 07:19:34 PM
"the holding period is suspended for the period Biotech Values 06/09/2015 11:14:35 AM
April 1st was the effective date of last Biotech Values 04/27/2015 04:20:41 PM
We are coming up on a year since Ariad Pharmaceuticals, Inc. 10/08/2014 06:37:37 PM
There are two paths ARIA can take. Path Ariad Pharmaceuticals, Inc. 09/17/2014 05:46:58 PM
I'm not sure Novo Nordisk's decision to return Biotech Values 04/13/2014 05:33:10 PM
This financing is highly dilutive but I believe Biotech Values 12/13/2013 06:42:44 PM
In order to determine the present value of Biotech Values 10/26/2013 11:24:42 AM
You won't get any argument from me that Biotech Values 09/23/2013 11:12:49 AM
The ARIA short thesis, as propagated by @adamfeuerstein, Biotech Values 09/22/2013 07:29:20 PM
I hadn't seen this one. Do you or Biotech Values 09/18/2013 09:06:56 AM
One clarification, the second-line patients I referenced achieved Biotech Values 09/13/2013 01:24:04 PM
Since CD47 is also expressed on healthy cells, Biotech Values 09/06/2013 03:09:00 PM
With 3Q GDP likely under 2% and inflation Biotech Values 08/27/2013 03:27:17 PM
Peter, your points are well-taken. In the end, Biotech Values 08/27/2013 11:41:40 AM
Stem Cell Therapeutics (SCTPF) is certainly highly speculative. Biotech Values 08/27/2013 09:54:21 AM
ARIA AP26113 Update included in "Abstracts not to Biotech Values 08/17/2013 12:39:28 PM
Abstract Titles for the upcoming ESMO/ECCO Conference are Biotech Values 08/17/2013 12:21:02 PM
I was very interested in EYEGUARD A/C expanding Biotech Values 08/08/2013 10:03:09 AM
Dose titration in front-line makes a lot of Biotech Values 07/31/2013 05:17:20 PM
Thx but there really isn't much to say Biotech Values 07/31/2013 04:36:01 PM
I think a lot of folks missed this Biotech Values 07/23/2013 01:09:37 PM
Xoma's EOA Ph2 data is now expected in Oct. Biotech Values 07/22/2013 09:25:37 AM
According to the Credit Suisse report, "Gleevec/Glivec is Biotech Values 07/16/2013 06:26:21 PM
"This is not an unfair report and is Biotech Values 07/16/2013 05:46:55 PM
I've never implicitly handicapped the three trials. I Biotech Values 07/10/2013 10:03:39 AM
To clarify my earlier post, I am drawing Biotech Values 07/07/2013 03:16:46 PM
You are right, you can't, but I was Biotech Values 07/07/2013 11:25:36 AM
I recently started a small position in the Biotech Values 07/07/2013 09:25:28 AM
the actual $3.3M of deferred revenue as of Biotech Values 07/03/2013 05:10:27 PM
Somewhat perversely, the narrower EU label (sprycel/tasigna failures) Biotech Values 07/02/2013 11:24:19 AM
SL-401 receives Orphan Drug designation in BPDCN. A Stemline Therapeutics 06/18/2013 05:05:38 PM
Stemline's June 2013 Corporate Presentation can be files.shareholder.com/d Stemline Therapeutics 06/18/2013 05:01:46 PM
ABBV, ARRY, CRIS, GILD, GLPG, INCY, SRPT are Biotech Values 06/16/2013 07:35:16 PM
XOMA ReadMeFirst Biotech Values 06/14/2013 08:00:48 AM
Not sure where you got the rant impression, Biotech Values 06/12/2013 09:54:28 AM
From the paper, 2.6% of patients with brain Biotech Values 06/10/2013 06:45:33 PM